On BCG Vaccine Protection from COVID-19: A Review

Bacille Calmette-Guérin (BCG) vaccine has been globally used to protect infants against tuberculosis (TB) for about a century. This vaccine has been shown to provide some degree of non-specific protection from other respiratory tract infections. This advantage has encouraged researchers to investiga...

Descripción completa

Detalles Bibliográficos
Autores principales: Bagheri, Narges, Montazeri, Hesam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Covid-19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956872/
https://www.ncbi.nlm.nih.gov/pubmed/33748676
http://dx.doi.org/10.1007/s42399-021-00835-1
_version_ 1783664537144131584
author Bagheri, Narges
Montazeri, Hesam
author_facet Bagheri, Narges
Montazeri, Hesam
author_sort Bagheri, Narges
collection PubMed
description Bacille Calmette-Guérin (BCG) vaccine has been globally used to protect infants against tuberculosis (TB) for about a century. This vaccine has been shown to provide some degree of non-specific protection from other respiratory tract infections. This advantage has encouraged researchers to investigate the potential protection of this vaccine from the coronavirus disease 2019 from different perspectives in the ongoing pandemic. In this study, we have comprehensively reviewed the latest articles on potential vaccine effectiveness of BCG on COVID-19 and summarized the possible impacts of the BCG against SARS-COV-2 in detail.
format Online
Article
Text
id pubmed-7956872
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-79568722021-03-15 On BCG Vaccine Protection from COVID-19: A Review Bagheri, Narges Montazeri, Hesam SN Compr Clin Med Covid-19 Bacille Calmette-Guérin (BCG) vaccine has been globally used to protect infants against tuberculosis (TB) for about a century. This vaccine has been shown to provide some degree of non-specific protection from other respiratory tract infections. This advantage has encouraged researchers to investigate the potential protection of this vaccine from the coronavirus disease 2019 from different perspectives in the ongoing pandemic. In this study, we have comprehensively reviewed the latest articles on potential vaccine effectiveness of BCG on COVID-19 and summarized the possible impacts of the BCG against SARS-COV-2 in detail. Springer International Publishing 2021-03-15 2021 /pmc/articles/PMC7956872/ /pubmed/33748676 http://dx.doi.org/10.1007/s42399-021-00835-1 Text en © The Author(s), under exclusive licence to Springer Nature Switzerland AG part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Covid-19
Bagheri, Narges
Montazeri, Hesam
On BCG Vaccine Protection from COVID-19: A Review
title On BCG Vaccine Protection from COVID-19: A Review
title_full On BCG Vaccine Protection from COVID-19: A Review
title_fullStr On BCG Vaccine Protection from COVID-19: A Review
title_full_unstemmed On BCG Vaccine Protection from COVID-19: A Review
title_short On BCG Vaccine Protection from COVID-19: A Review
title_sort on bcg vaccine protection from covid-19: a review
topic Covid-19
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956872/
https://www.ncbi.nlm.nih.gov/pubmed/33748676
http://dx.doi.org/10.1007/s42399-021-00835-1
work_keys_str_mv AT bagherinarges onbcgvaccineprotectionfromcovid19areview
AT montazerihesam onbcgvaccineprotectionfromcovid19areview

Ejemplares similares